ArticleDevelopment (Cambridge, England)2026

Reduced TBX5 dosage undermines developmental control of atrial cardiomyocyte identity in a model of human atrial disease.

Irfan S Kathiriya et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.